Gria3 Peptide - N-Terminal Region Blocking Peptide

Name: Gria3 Peptide - N-Terminal Region Blocking Peptide; MyBioSource
Brand: MyBioSource
SKU: MBS3227451
Price: 195 USD
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS3227451

This is a synthetic peptide designed for use in combination with anti-Gria3 Antibody, madeTarget Description: The function of Gria3 remains unknown. More details

$195 / 0.1 mg +1 FREE 8GB USB

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

Gria3, Blocking Peptide

Full Product Name

Gria3 Peptide - N-terminal region

Product Gene Name

Gria3 blocking peptide

Product Synonym Gene Name

2900064I19Rik; GluR-C; GluR-K3; Glur-3; Glur3; Gluralpha3; KIAA4184; mKIAA4184; GluA3

Sequence

EEMDRRQEKR YLIDCEVERI NTILEQVVIL GKHSRGYHYM LANLGFTDIV

Species Reactivity

Mouse

Form/Format

Lyophilized powder

Preparation and Storage

Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20 degree C. Avoid repeat freeze-thaw cycles.

Antibody/Peptide Pairs

Gria3 peptide (MBS3227451) is used for blocking the activity of Gria3 antibody (MBS3202473)

Molecular Weight

100kDa

Product Categories/Family for Gria3 blocking peptide

Peptide

Applications Tested/Suitable for Gria3 blocking peptide

Western Blot (WB)

Other Notes

Small volumes of Gria3 blocking peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Gria3 purchase

MBS3227451 is a blocking peptide targeting Gria3. Also known as Gria3 Peptide - N-terminal region. Reactive in Mouse.

Additional Details

NCBI/Uniprot data below describe general gene information for Gria3. It may not necessarily be applicable to this product.

NCBI GI #

163792196

NCBI GeneID

53623

NCBI Accession #

NP_058582

UniProt Primary Accession #

A2VDF5

UniProt Related Accession #

Q9Z2W9

GenBank Nucleotide #

NM_016886

NCBI Official Full Name

glutamate receptor 3 isoform a

NCBI Official Synonym Full Names

glutamate receptor, ionotropic, AMPA3 (alpha 3)

NCBI Official Symbol

Gria3

NCBI Official Synonym Symbols

GluA3; Glur3; GluR-C; Glur-3; GluR-K3; Gluralpha3; 2900064I19Rik

Protein Family

Glutamate receptor

NCBI Protein Information

glutamate receptor 3

NCBI Summary for Gria3

This gene encodes a multi-pass transmembrane protein that forms a homotetramer or heterotetramer in neuronal cells. The encoded protein is a ligand-gated ion channel that responds to the neurotransmitter L-glutamate to promote synaptic transmission. Deficiency of this gene leads to behavioral phenotypes. The transcript is subject to RNA editing at codon 769 (AGA->GGA; R->G). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]

Research Articles on Gria3

1. The central distribution of AMPARs is absent in GluA3-knockout mice, and gold particles are evenly distributed along the postsynaptic density. GluA4 gold labeling was homogenously distributed along both synapse types. Thus, GluA3 and GluA4 subunits are distributed at auditory nerve synapses in a target-cell-dependent manner.

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Pathways associated with Gria3 blocking peptide

Products by Pathway	Pathway Diagram
Activation Of AMPA Receptors Pathway antibodies	Activation Of AMPA Receptors Pathway Diagram
Activation Of NMDA Receptor Upon Glutamate Binding And Postsynaptic Events Pathway antibodies	Activation Of NMDA Receptor Upon Glutamate Binding And Postsynaptic Events Pathway Diagram
Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity Pathway antibodies	Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity Pathway Diagram
Glutamatergic Synapse Pathway antibodies	Glutamatergic Synapse Pathway Diagram
Glutamatergic Synapse Pathway antibodies	Glutamatergic Synapse Pathway Diagram
Hypothetical Network For Drug Addiction Pathway antibodies	Hypothetical Network For Drug Addiction Pathway Diagram
Long-term Depression Pathway antibodies	Long-term Depression Pathway Diagram
Long-term Depression Pathway antibodies	Long-term Depression Pathway Diagram
Neuroactive Ligand-receptor Interaction Pathway antibodies	Neuroactive Ligand-receptor Interaction Pathway Diagram
Neuroactive Ligand-receptor Interaction Pathway antibodies	Neuroactive Ligand-receptor Interaction Pathway Diagram

Diseases associated with Gria3 blocking peptide

Disease Name	Pubmed Publications
Mental Disorders Antibodies	>11 publications with Gria3 and Mental Disorders
Genetic Diseases, Inborn Antibodies	>5 publications with Gria3 and Genetic Diseases, Inborn
Mental Retardation, X-Linked Antibodies	>5 publications with Gria3 and Mental Retardation, X-Linked
Anxiety Disorders Antibodies	>4 publications with Gria3 and Anxiety Disorders
Schizophrenia Antibodies	>3 publications with Gria3 and Schizophrenia
Epilepsy Antibodies	>2 publications with Gria3 and Epilepsy
Neoplasms Antibodies	>1 publications with Gria3 and Neoplasms
Cognition Disorders Antibodies	>1 publications with Gria3 and Cognition Disorders
Genital Diseases, Male Antibodies	>1 publications with Gria3 and Genital Diseases, Male
Seizures Antibodies	>1 publications with Gria3 and Seizures

Organs/Tissues associated with Gria3 blocking peptide

Organ/Tissue Name	Pubmed Publications
Brain Antibodies	>9 publications with Gria3 and Brain
Spinal Cord Antibodies	>1 publications with Gria3 and Spinal Cord
Embryonic Tissue Antibodies	>1 publications with Gria3 and Embryonic Tissue